Search Results - "Martinez Monge, Rafael"

Refine Results
  1. 1

    Radiation effects on antitumor immune responses: current perspectives and challenges by Walle, Thomas, Martinez Monge, Rafael, Cerwenka, Adelheid, Ajona, Daniel, Melero, Ignacio, Lecanda, Fernando

    Published in Therapeutic Advances in Medical Oncology (01-01-2018)
    “…Radiotherapy (RT) is currently used in more than 50% of cancer patients during the course of their disease in the curative, adjuvant or palliative setting. RT…”
    Get full text
    Book Review Journal Article
  2. 2

    Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): dosimetric comparison and clinical implications by Arbea, Leire, Ramos, Luis Isaac, Martínez-Monge, Rafael, Moreno, Marta, Aristu, Javier

    Published in Radiation oncology (London, England) (26-02-2010)
    “…To compare target dose distribution, comformality, normal tissue avoidance, and irradiated body volume (IBV) in 3DCRT using classic anatomical landmarks…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    ENPP1 Immunobiology as a Therapeutic Target by Ruiz-Fernández de Córdoba, Borja, Martínez-Monge, Rafael, Lecanda, Fernando

    Published in Clinical cancer research (13-06-2023)
    “…ENPP1 (ecto-nucleotide pyrophosphatase/phosphodiesterase) participates in the hydrolysis of different purine nucleotides in an array of physiologic processes…”
    Get full text
    Journal Article
  12. 12

    Comparison of limited-volume perioperative high-dose-rate brachytherapy and wide-field external irradiation in resected head and neck cancer by Gaztañaga, Miren, Pagola, María, Cambeiro, Mauricio, Ruiz, Maria E. Rodriguez, Aristu, Javier, Montesdeoca, Néstor, Alcalde, Juan, Martínez-Monge, Rafael

    Published in Head & neck (01-08-2012)
    “…Background This study aimed to test the safety of using perioperative high‐dose‐rate brachytherapy (PHDRB) in resected head and neck cancer. Methods From 2000…”
    Get full text
    Journal Article
  13. 13

    Interaction of 2-Gy Equivalent Dose and Margin Status in Perioperative High-Dose-Rate Brachytherapy by Martínez-Monge, Rafael, M.D, Cambeiro, Mauricio, M.D, Moreno, Marta, M.D, Gaztañaga, Miren, M.D, San Julián, Mikel, M.D, Alcalde, Juan, M.D, Jurado, Matías, M.D

    “…Purpose To determine patient, tumor, and treatment factors predictive of local control (LC) in a series of patients treated with either perioperative…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Clinical Management of Small-Cell Carcinoma of the Urinary Tract: A 10-Year Single-Center's Experience by Carranza, Omar E, Castañón, Eduardo, Abella, Luis E, Zudaire, María E, Castillo, Ainhoa, Arévalo, Estefanía, Fusco, Juan P, Zudaire, Juan J, Carías, Rafael, Cambeiro, Mauricio, Martínez-Monge, Rafael, Gil-Bazo, Ignacio

    Published in Clinical genitourinary cancer (01-06-2013)
    “…Micro-Abstract There is controversy about the ideal clinical management of small-cell cancer of the urinary tract (SCCUT). The neuron-specific enolase (NSE)…”
    Get full text
    Journal Article
  20. 20